Medtrum Overview

  • Founded
  • 2008
Founded
  • Status
  • Private
  • Latest Deal Type
  • Series C
  • Latest Deal Amount
  • $29M
Latest Deal Amount
  • Investors
  • 8

Medtrum General Information

Description

Developer of diabetes management devices. The company develops and markets devices and related software used to manage and monitor glucose levels and insulin pump status of diabetic patients.

Contact Information

Website
www.medtrum.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Electronics (B2C)
Other Industries
Application Software
Primary Office
  • Building 3, No. 200 Newton Road, Zhangjiang Hi-Tech Park
  • Shanghai
  • China
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Medtrum Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Later Stage VC (Series C) 24-Dec-2018 $29M 0000 Completed Generating Revenue
2. Later Stage VC 16-Nov-2014 Completed Generating Revenue
1. Early Stage VC 31-Mar-2010 Completed Generating Revenue
To view Medtrum’s complete valuation and funding history, request access »

Medtrum Patents

Medtrum Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20200052273-A1 Pulp paper for flexible batteries and the preparation method thereof Granted 17-Feb-2017 0000000000
US-10879511-B2 Pulp paper for flexible batteries and the preparation method thereof Active 17-Feb-2017 000000000
EP-3583641-A1 A pulp paper for flexible batteries and the preparation method thereof Pending 17-Feb-2017 000000000
EP-3583641-A4 A pulp paper for flexible batteries and the preparation method thereof Pending 17-Feb-2017 000000000 0
US-20190314572-A1 Closed loop control algorithm for an artificial pancreas Pending 30-Dec-2016 A61B5/14532

Medtrum Executive Team (2)

Name Title Board Seat Contact Info
Cuijun Yang Chief Executive Officer
Jie Lu Manager, Marketing
To view Medtrum’s complete executive team members history, request access »

Medtrum Investors (8)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
3E Bioventures Capital Venture Capital Minority 000 0000 000000 0
BOCGI Zheshang Capital Other Minority 000 0000 000000 0
Morningside Group Venture Capital Minority 000 0000 000000 0
Shanghai Nuokai Investment Management Venture Capital Minority 000 0000 000000 0
Sequoia Capital China Venture Capital Minority 000 0000 000000 0
You’re viewing 5 of 8 investors. Get the full list »